Prognostic value of posttreatment HPV-specific antibodies in patients with oropharyngeal tumors.

Simona SimonidesovaEva HamsikovaViera LudvikovaJan KlozarOndrej VencalekRuth Tachezy

Published in: Journal of surgical oncology (2019)

The data suggest that the pretreatment level of HPV-specific antibodies is not predictive of the occurrence of recurrences but the decrease HPV16 E6 antibodies on the 1-year follow-up is predictive of better survival of HN patients.

Keyphrases

high grade
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
cervical cancer screening
electronic health record
big data
machine learning
patient reported